B.H.E. Jansen

Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer

Matthijs C. F. Cysouw, B.H.E. Jansen, Tim van de Brug et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 134 citations · Full text

Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

B.H.E. Jansen, Yves J. L. Bodar, Gerben J.C. Zwezerijnen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 104 citations · Full text

Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer

Maurits Wondergem, B.H.E. Jansen, Friso M. van der Zant et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 69 citations · Full text

Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy

B.H.E. Jansen, Pim J. van Leeuwen, Maurits Wondergem et al. · European Urology Oncology · 2020 · 69 citations

Urology, Biochemical Recurrence, Oncologic Imaging +13

Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

Yves J. L. Bodar, B.H.E. Jansen, J. Patrick van der Voorn et al. · World Journal of Urology · 2020 · 45 citations · Full text